Back to Journals
International Journal of Nanomedicine
Department of Medicine and Biopharmaceutical Sciences, University of Illinois at Chicago, United States
Editor-in-Chief: Dr Israel Rubinstein
Dr Israel Rubinstein is professor of medicine in the College of Medicine at the University of Illinois at Chicago. He is a member of the Section of Pulmonary, Critical Care, Allergy and Sleep Medicine at the Department of Medicine, University of Illinois at Chicago, and attending physician at the University of Illinois at Chicago Medical Center and Jesse Brown VA Medical Center, Chicago, Illinois, USA. Dr Rubinstein received his medical degree from the Hebrew University–Hadassah School of Medicine in Jerusalem. He was a medical resident in Israel, fellow in respirology at the University of Toronto and research fellow at the Cardiovascular Research Institute, University of California at San Francisco. He is board-certified in internal medicine and pulmonary disease. Dr Rubinstein holds 18 issued and pending US and international patents and has authored more than 190 peer-reviewed articles in scientific journals.
Dr Rubinstein’s research interests include nanomedicine, targeted drug delivery, and bioimaging. Dr Rubinstein is the Editor-in-Chief of the International Journal of Nanomedicine and associate editor of the Journal of Biomedical Nanotechnology and member of the editorial board of several scientific journals. He is a member of the Scientific Advisory Board of the International Academy of Cardiology. Dr Rubinstein is a fellow of the American Heart Association, American College of Physicians and American College of Chest Physicians. In addition, he is a member of the American Thoracic Society, American Physiological Society, American Society for Pharmacology and Experimental Therapeutics, American Microbiology Society and the Microcirculatory Society. He is a board member and director of Advanced Life Sciences, a publicly-traded biopharmaceutical company in Woodridge, Illinois, USA, engaged in the discovery, development and commercialization of drugs in the areas of infection, cancer and respiratory disease.
Prof. Dr. Khang
Department of Physiology, School of Medicine, Gachon University, Korea, Republic of (South)
East Asia Associate Editor: Dongwoo Khang
Dr Khang is a Professor of Physiology at Gachon Medical School. His nanomedicine lab raised funds of more than $5 million for the National Research Foundation in South Korea. He has published over 80 research articles in major leading journals, including Advanced Science, ACS Nano, Biomaterials, ACS Applied Materials and Interfaces, and Nanoscale. His recent research areas are focused on translational medicine in oncology and immunology with the aid of nanomedicine.
He completed his PhD in physics and biomedical engineering at Purdue University. Then he served as a post-doctor in Brown University at the School of Engineering for two years. He worked as a faculty member in Gyeonsang National University from 2009 before joining the School of Medicine, Gachon University. He received MS and BS degrees from Seoul National University and Kyunghee University, respectively.
Prof. Dr. Lobo
Department of Materials Engineering, Universidade Federal do Piauí, Brazil
South American Associate Editor: Prof. Dr. Anderson Lobo
Professor Anderson de Oliveira Lobo’s (H index: 21) degrees are in Biomedical Engineering from Universidade do Vale do Paraiba (Brazil, B.S., 2005) and in Materials Science from Technological Institute of Aeronautics (Brazil, Ph.D., 2011). Professor Lobo has graduated/supervised over 90 post-doctoral students, thesis completing B.S., M.S., and undergrads students. Professor Lobo has over 90 published papers, 2 provisional patents on the applications of nanomaterials for tissue engineering, and over 300 papers presented in conferences. Professor Lobo serves as Adhoc advisor of several international journals and Brazilian and international grant agencies.
Stanford Cardiovascular Institute, Department of Medicine, Stanford University, United States
Ebrahim Mostafavi is currently at Stanford Cardiovascular Institute, Stanford School of Medicine. His research interests revolve around the use of cardiac iPS cells to design and develop in vitro models (organoids, 3D bioprinted constructs, vascular grafts) for cardiovascular disease modeling and drug screening, as well as CRISPR/Cas gene-editing for cardiovascular diseases. Dr. Mostafavi received his PhD in Chemical Engineering (with a focus on Biomedical Engineering and Regenerative Medicine) from Northeastern University, Boston, MA. During his doctoral training, he received several prestigious awards. He has also received training at Harvard Medical School/Brigham and Women's Hospital on engineering and development of (nano)biomaterials and 3D scaffolds (hydrogels, 3D bioprinted constructs, and nanoporous scaffolds) to create biologically complex tissues and organs for tissue engineering, regenerative medicine, and translational applications.
Dr. Mostafavi currently serves as an Editorial Board Member for Nature Scientific Reports, Springer Nature Journal of Nanostructure in Chemistry, MDPI Functional Biomaterials, and a few other prestigious journals. He also serves as a verified peer-reviewer for over 25 different high-impact journals from respected publishers. His scholarly work consists of > 65 publications with an H-index of 20 (i10-index= 34) on Google Scholar Profile. Thus far, he contributed to >10 book chapters and was selected as the editor of a few books including “Advances in Cardiovascular Biomaterials” and "Emerging Nanomaterials to Combat Antimicrobial Resistance"
Pharmaceutics, China Pharmaceutical University, China Mainland (PRC)
Associate Editor: Yan Shen
Dr. Yan Shen is an Associate Professor of the Department of Pharmaceutics at the China Pharmaceutical University. Her research interests focus on the design of theranostic nanoplatform for tumor treatment, developing new excipients and technologies for micro-particulate formulations as pulmonary inhaled preparations (i.e. Dry Powder Inhalations), and efficient nonviral carriers for siRNA delivery. Dr Shen has authored over 30 peer-reviewed papers, 2 patents, and 2 book chapters. Her research was rewarded with the Third Prize Award of Oncology Medicine Science and Technology in the Jiangsu Province in 2016 and the Shimazu Young Scholar Award in 2019.
She completed her Ph.D. in Pharmaceutics at China Pharmaceutical University. Then she worked as a faculty member in China Pharmaceutical University from 2010 and served as a visiting scholar at Northeastern University for one year from 2016 to 2017. She received her MS and BS degrees from the China Pharmaceutical University in 2007 and 2004, respectively.
Clinical Biochemistry, Sher-i-Kashmir Institute of Medical Sciences, India
Consulting Editor: Farooq A. Shiekh (PhD)
Farooq A Shiekh is the Chair of Research and Head, Department of Biochemistry, Government Medical College (GMC) & Associated Hospital, Baramulla, India. He is a former Professor, Department of Basic Medical Sciences, Avalon University School of Medicine, Curacao, Netherlands, Antilles (2013-2016). He obtained his doctorate degree in biomedical sciences- the biochemical characterization of small particles, from one of the prestigious medical center, the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, India (PhD, 2005).
In order to pursue his great interests in the field of nanoparticles, he joined at Mayo Clinic, Rochester, MN, USA, as a fellow (2007-2009) and trained as senior scientist at Faculte of de Medecine, National Center for Scientific Research (CNRS) and WHO collaborative center, La Timone Hospital, Marseille, France (2010-2012). His area of research is advancing ‘nanocarriers’ for combined targeted medicine, in order to enhance efficacy of drug delivery to reach untargetable complex tumor sites.
Dr. Shiekh also served as the consulting editor for the International Journal of Nanomedicine (2015-2019) and is associated with many other scientific organizations. He has many years of diverse teaching and research experience from renowned medical institutions of world repute.
Wenzhou Institute of Biomaterials and Engineering, Chinese Academy of Sciences, China Mainland (PRC)
Associate Editor - China: Linlin Sun
Dr. Linlin Sun is a research professor in Wenzhou Institute of Biomaterials and Engineering, Chinese Academy of Sciences. Her research interests focus on self-assembled nanomaterials for regenerative medicine, drug delivery, and antibacterial applications. She has authored over 4 review papers, 25 peer-reviewed journal papers, and three patents. For technological transitions, she has collaborated with biomedical companies for 5 years, and developed 3 products.
She completed her Ph.D. first three years at Brown University and last two years at Northeastern University, and obtained a Ph.D. in Bioengineering at Northeastern University in 2014. Before joining the Ph.D. program, Linlin worked as a research assistant professor in Changchun Institute of Applied Chemistry of Chinese Academy of Sciences for three years. She received her MS in Biochemical Engineering from University College London in 2005 and a BS in Bioengineering from Beijing Institute of Technology in 2004.
Mechanical Medical and Process Engineering, Queensland University of Technology, Australia
Associate Editor: Phong Tran
Dr Tran (Senior Lecturer & Research Fellow, Science and Engineering, Queensland University of Technology, Australia, Fellow of Engineers Australia – Biomedical Engineering) received his PhD in Biophysics and Biomaterials (2010), MSc in Electrical Science and Computer Engineering (2009) from Brown University. He joined QUT in 2015 and established the Interface Science and Materials Engineering group.
Dr Tran’s research interest includes nano-biomaterials, surface modification, bio-material interfaces, local drug delivery, infection control, cancer treatment, tissue response and regeneration. He is an emerging mid-career scientist with 54 publications, 1 US patent (granted), an h-index of 15 (google scholar). As a Chief Investigator, he has been awarded research grants of more than $4.5M from funding bodies such as Australian Research Council (ARC), Queensland Government, Australian Academy of Technology and Engineering.
Division of Engineering in Medicine, Brigham and Women's Hospital, Department of Medicine, Harvard Medical School, United States
Associate Editor: Mian Wang
Mian Wang is a postdoctoral researcher at Harvard Medical school/Brigham and Women's Hospital, as well as a research affiliate of MIT. He received his Bachelor in Biotechnology at Shandong University and his Ph. D. in Chemical Engineering at Northeastern University. His work was focused on nanomaterials for drug delivery, immunotherapy, and anti-inflammation, as well as nanotechnology for tissue engineering. Currently, he is working on nanomaterials for drug delivery and tissue regeneration. He has authored 26 peer-reviewed journal paper, 3 book chapters, 5 conference proceedings, 2 patents and he has presented his work on over 30 conferences.
School of Health Sciences and Biomedical Engineering, Hebei University of Technology, China Mainland (PRC)
Associate Editor - China: Lei Yang
Lei Yang is currently a professor at the Institute of Orthopaedics, Soochow University (Suzhou, China). He received his PhD (2011) in engineering and MS (2011) in innovation management and entrepreneurship from Brown University (Providence, USA) and both ME (2006) and BE (2004) in materials science and engineering from Tsinghua University (Beijing, China). Before joining the Soochow University in 2012, Lei worked as lecturer and postdoc in the School of Engineering at Brown University. His research interests focus on novel biomaterials for orthopedic applications and mechanistic study on cell-material interactions. He has authored at least three book chapters, 23 peer-reviewed journal papers, 7 conference proceedings and four patents. He is an editorial member of the Nano Bulletin and serves on the review panels of over 27 international research journals. He is also the recipient of a number of awards, including the National 1000 Young Talents (China), the Fresh Face Young Scientist of Sigma Xi (USA), the Society For Biomaterials (SFB) Student Award for Outstanding Research (USA), the Materials Research Society (MRS) Graduate Student Silver Award (USA) and the Chinese Government Award For Outstanding Students Abroad.
Department of Mechanical and Aerospace Engineering; Biomedical Engineering and Medicine, The George Washington University, United States
Associate Editor - Lijie Grace Zhang
Dr. Lijie Grace Zhang is an associate professor in the Department of Mechanical and Aerospace Engineering, Department of Biomedical Engineering and Department of Medicine at the George Washington University. She obtained her Ph.D. in Biomedical Engineering at Brown University in 2009. Dr. Zhang joined GW in 2010, after finishing her postdoctoral training at Rice University and Harvard Medical School. She is the director of the Bioengineering Laboratory for Nanomedicine and Tissue Engineering at GW. She has received the NIH Director’s New Innovator Award, Young Innovator in Cellular and Molecular Bioengineering, GW SEAS Outstanding Young Researcher Award, John Haddad Young Investigator Award by American Society for Bone and Mineral Research, GWU SEAS Faculty Recognition Award, Early Career Award from the International Journal of Nanomedicine, Ralph E. Powe Junior Faculty Enhancement Award by the Oak Ridge Associated Universities Organization, Joukowsky Family Foundation Outstanding Dissertation Award at Brown and the Sigma Xi Award. Her research interests include nanomedicine, 3D bioprinting, complex tissue engineering, stem cell engineering, drug delivery and breast cancer bone metastasis. Dr. Zhang has authored 2 books, over 74 journal papers, book chapters and conference proceedings, 4 patents and has presented her work on over 190 conferences, university and institutes.
Mohammad Abdollahi, PharmD, PhD, FIAS, Professor and Head, Department of Toxicology and Pharmacology at Faculty of Pharmacy, and Head of The Institute of Pharmaceutical Sciences (TIPS), Tehran University of Medical Sciences, Tehran, Iran.
Vivek Agrahari, Ph.D., Scientist, CONRAD, Eastern Virginia Medical School (EVMS), Arlington, VA, USA
Raj Bawa, MS, PhD, MD, is president of Bawa Biotech LLC, a biotech/pharma consultancy and patent law firm based in Ashburn, Virginia, USA. Trained as a microbiologist and biochemist, he is an inventor, author, entrepreneur, professor, and registered patent agent (since 2002) licensed to practice before the US Patent Office. He is currently a scientific advisor to Teva (since 2010), visiting research scholar at Albany College of Pharmacy, founding director of the American Society for Nanomedicine (established in 2008), and VP at Guanine, Inc., Rensselaer, NY. He has served as a principal investigator of various research grants, most recently as a principal investigator of a CDC grant to develop an assay for carbapenemase resistant bacteria. After earning a BSc (Honors School) in microbiology, he earned a MS (cancer biology), a PhD (biophysics/biochemistry) and an MD. In the 1990s, Dr. Bawa held various positions at the US Patent & Trademark Office, including primary examiner from 1996–2002.
Susmita Bose, Ph.D., Herman and Brita Lindholm Endowed Chair Professor, School of Mechanical and Materials Engineering, Washington State University, Pullman, WA, USA
Salvatore Cannistraro, Professor of Physics and Biophysics, Biophysics and Nanoscience, Scientific Director of the Biophysics and Nanoscience Centre, University of Tuscia, Viterbo, Italy
Esther Chang, Professor of Oncology, Georgetown University Medical Center, Washington, DC, USA
Young Wook Chun, Assistant Professor of Cardiovascular Medicine, Health Sciences Facility III, University of Maryland School of Medicine, Baltimore, MD, USA
Prof. Dr. Ciofani
Gianni Ciofani, Associate Professor, Research Director, Smart Bio-Interfaces, Italian Institute of Technology, Pontedera (Pisa), Italy.
Prof. Dr. Comes Franchini
Mauro Comes Franchini, Department of Industrial Chemistry “Toso Montanari", University of Bologna, Bologna, Italy
Harold G. Craighead, Charles W. Lake Jr Professor of Engineering, Professor of Applied and Engineering Physics, Cornell University, Ithaca, NY, USA
Xiaohong Fang, Professor of Chemistry, Beijing National Research Center for Molecular Sciences, Key Laboratory of Molecular Nanostructures and Nanotechnology, Institute of Chemistry, Chinese Academy of Sciences, Beijing, People's Republic of China.
Prof. Dr. Fenniri
Hicham Fenniri, received all his degrees from the University of Strasbourg, France. After a postdoctoral fellowship at the Scripps Research Institute, CA, USA, he moved to Purdue University, IN, USA, where he initiated his independent academic career (1997-2003), and established the Purdue Laboratory for Chemical Nanotechnology. In 2003, He joined the National Research Council as a founding member of the National Institute for Nanotechnology and as professor of chemistry and bioengineering at the University of Alberta (Canada, 2003-2013). Dr. Fenniri is currently Professor of Chemical Engineering, Bioengineering, Chemistry & Chemical Biology at Northeastern University, Boston, MA, USA. Dr. Fenniri’s contributions appeared in over 220 publications, 20 patents and patent applications, and over 500 contributed national and international conference papers. Dr. Fenniri has also lectured extensively around the globe and has been an invited professor at several institutes and universities.
Robert A. Freitas Jr, Institute for Molecular Manufacturing, Palo Alto, CA, USA
Dr. Suresh Gadde, Department of Biochemistry, Microbiology and Immunology, Faculty of Medicine, University of Ottawa, Canada.
Rogerio Sa Gaspar, Professor of Pharmaceutics, Faculdade de Farmácia da Universidade de Lisboa, Lisboa, Portugal
Gershon Golomb, Professor of Pharmaceutics, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel
Maling Gou, Professor, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, People's Republic of China
Mark Gumbleton, College of Biomedical and Life Sciences, School of Pharmacy & Pharmaceutical Sciences, Cardiff University, Cardiff, UK
Justin S. Hanes, Lewis J. Ort Professor, Director, The Center for Nanomedicine at the Wilmer Eye Institute, Johns Hopkins University School of Medicine, Baltimore, MD, USA
Hossein Jahangirian, Department of Chemical Engineering, Engineering Center, Northeastern University, Boston, MA, USA
Kazunori Kataoka, Institute for Future Initiatives, The University of Tokyo, Japan
Ajeet Kaushik, Ph.D., Assistant Professor of Chemistry, NanoBioTech Laboratory, Health System Engineering, Department of Environmental Engineering, Florida Polytechnic University, USA.
Sung Yeol Kim, Associate Professor, School of Mechanical Engineering, Kyungpook National University, Dae-gu, South Korea
Deok-Ho Kim, Department of Biomedical Engineering, School of Medicine, Johns Hopkins University, Baltimore, MD, USA
Wolfgang G. Kreyling (PhD), Researcher Emeritus and External Scientific Advisor, Institute of Epidemiology II, Helmholtz Zentrum München, German Research Center for Environmental Health, Munich, Germany. Wolfgang G. Kreyling's research interests range from aerosol sciences and nanoparticle technology to biophysics of the lungs reaching from the particle characterization to dosimetry and nanoparticle lung interactions on the level of the entire organism, cells like alveolar macrophages, and molecular compounds.
Cato T. Laurencin, University Professor; Albert and Wilda Van Dusen Distinguished Professor of Orthopaedic Surgery; Professor of Chemical and Biomolecular Engineering; Professor of Materials Science and Engineering; Professor of Biomedical Engineering; Director, The Raymond and Beverly Sackler Center for Biomedical, Biological, Physical and Engineering Sciences; Chief Executive Officer, The Connecticut Convergence Institute for Translation in Regenerative Engineering, The University of Connecticut, Storrs, CT, USA
Prof. Dr. Li
Chenzhong Li, Nano-Theranostics/ Bioelectronics Lab, Department of Biomedical Engineering, Florida International University, USA
Yuehe Lin, Ph.D., Professor, School of Mechanical and Materials Engineering; Adjunct Professor, Chemistry, Chemical Engineering and Bioengineering, Paul G. Allen School for Global Health, Fellow of AAAS, AIMBE, NAI, ECS, RSC, WSAS, Washington State University Pullman, WA, USA.
Feng-Huei Lin, Tenure, Institute of Biomedical Engineering, National Taiwan University, Taiwan. Director, Institute of Biomedical Engineering and Nanomedicine, National Health Research Institutes (NHRI).
Ping Ma, Scientist III, Hikma Pharmaceuticals, Bedford, OH, USA
Kasturi Muthoosamy, Associate Professor, Centre for Nanotechnology, University of Nottingham, Malaysia.
Joseph Pergolizzi Jr, Co-Founder and Chief Operating Officer of NEMA Research, Naples, FL, USA
Xiaoyang Qi, PhD, Professor of Medicine and Pediatrics, Co-Division Chief for Basic Science Research, University of Cincinnati College of Medicine, Cincinnati, Ohio, USA
Mehrdad Shadmehr, PhD, Organic Chemistry, Postdoctoral Research Associate, Department of Chemistry, University of Virginia at Charlottesville, USA.
Farooq A. Shiekh, Associate Professor & Head, Government Medical College & Associated Hospital, Baramulla, India.
Tolou Shokuhfar, Associate Professor, Department of Bioengineering, Director, In-situ Nanomedicine Laboratory, University of Illinois at Chicago, USA.
Eduardo Sobarzo-Sánchez, full Professor at the Medicinal and Bioinorganic Chemistry-Research Group (QMEDBIN, https://www.sobarzosanchez.com/qmedbin-presentation), Instituto de Investigación y Postgrado, Facultad de Ciencias de la Salud, Universidad Central de Chile, Chile.
Srinivas Sridhar, Director, Nanomedicine Academy, University Distinguished Professor of Physics, Bioengineering and Chemical Engineering, Northeastern University, and Lecturer, Harvard Medical School, Boston, MA, USA
Vicki Stone BSc PhD FIBiol FRSE, Professor, Institute of Biological Chemistry, Biophysics and Bioengineering, Heriot-Watt University, Edinburgh, UK
Yaying Sun, Ph.D. Research associate in regenerative Medicine, Orthopedics, and related Cellular Biology, Department of Sports Medicine, Huashan Hospital, Fudan University, China.
Vladimir P Torchilin, University Distinguished Professor of Pharmaceutical Sciences, Director, Center for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston, MA, USA
Dr Fabio Variola, Faculty of Engineering, Department of Mechanical Engineering, Faculty of Medicine, Department of Cellular and Molecular Medicine, University of Ottawa, Affiliate Investigator at the Children’s Hospital of Eastern Ontario (CHEO), Ontario, Canada.
Juan L. Vivero-Escoto, Associate Professor, Department of Chemistry, University of North Carolina Charlotte, Charlotte, NC, USA.
Professor Luning Wang, Laboratory of Advanced Healthcare Materials, School of Materials Science and Engineering, University of Science and Technology Beijing, No. 30, Xueyuan Road, Haidian District, Beijing, China.
Prof. Dr. Wang
You Wang, Professor, Harbin Institute of Technology, Heilongjiang, China.
Thomas J. Webster, Consultant, Founding Editor-in-Chief; Department Chair and Professor, Chemical Engineering, Northeastern University, Boston, MA, USA
Karen L. Wooley, W. T. Doherty-Welch Chair in Chemistry, University Distinguished Professor, Director, Laboratory for Synthetic-Biologic Interactions, Department of Chemistry, Texas A&M University, College Station , TX, USA
Tohru Yamada, Associate Professor in Oncology, Department of Surgery, Division of Surgical Oncology, University of Illinois at Chicago, Illinois, USA.
Nan Yao, Professor and Director of the PRISM Imaging and Analysis Center, Materials Science and Engineering, Princeton University, USA
Prof. Dr. Zhu
Xiangdong Zhu, Ph.D., Professor, National Engineering Research Center for Biomaterials, Sichuan University, Chengdu, China.